Net Cash Provided by (Used in) Operating Activities |
-546 |
USD |
-62% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
546 |
USD |
+20.3% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
50B |
shares |
0% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
3.33B |
shares |
+340% |
Q3 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
0 |
USD |
-100% |
Q3 2024 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
1.6M |
USD |
+14.4% |
Q2 2024 |
FY 2024 |
Cash and Cash Equivalents, Period Increase (Decrease) |
-353 |
USD |
|
Q3 2022 |
Q1 2022 |
Depreciation |
93 |
USD |
-59.6% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.6M |
USD |
+14.4% |
Q2 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
200 |
shares |
0% |
Q3 2024 |
Q1 2025 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2024 |
Q1 2025 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2024 |
FY 2024 |
Additional Paid in Capital |
14.7M |
USD |
+1.8% |
Q3 2024 |
Q1 2025 |
Preferred Stock, Shares Outstanding |
200 |
shares |
0% |
Q3 2024 |
Q1 2025 |
Current Federal Tax Expense (Benefit) |
0 |
USD |
|
Q3 2022 |
Q1 2022 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q2 2024 |
FY 2024 |
Interest Expense |
503K |
USD |
+39.3% |
Q1 2024 |
Q3 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q1 2025 |